Wellington Management Group LLP Purchases 857,526 Shares of Revvity Inc. $RVTY

Wellington Management Group LLP raised its position in shares of Revvity Inc. (NYSE:RVTY) by 10,653.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 865,575 shares of the company’s stock after purchasing an additional 857,526 shares during the period. Wellington Management Group LLP’s holdings in Revvity were worth $96,304,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of RVTY. AQR Capital Management LLC increased its position in shares of Revvity by 5.2% during the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after purchasing an additional 420 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Revvity by 6.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after buying an additional 744 shares during the last quarter. Millennium Management LLC boosted its stake in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after buying an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after acquiring an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth grew its position in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after acquiring an additional 811 shares during the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Trading Down 1.6%

Shares of RVTY opened at $126.59 on Wednesday. The stock has a market capitalization of $14.13 billion, a P/E ratio of 60.28, a PEG ratio of 2.34 and a beta of 1.09. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $130.07. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The firm has a fifty day simple moving average of $115.22 and a two-hundred day simple moving average of $101.55.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The firm had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, research analysts anticipate that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s payout ratio is currently 13.33%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on RVTY shares. Wolfe Research began coverage on shares of Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Evercore reiterated an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. JPMorgan Chase & Co. lowered their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus reduced their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Revvity presently has a consensus rating of “Hold” and a consensus price target of $110.58.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.